These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16479097)

  • 21. Antithrombotic drugs for the secondary prevention of ischemic stroke.
    Nenci GG; Goracci S
    Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin and clopidogrel: efficacy and resistance in diabetes mellitus.
    Angiolillo DJ; Suryadevara S
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):375-88. PubMed ID: 19520310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clopidogrel: new preparation. An alternative to aspirin.
    Prescrire Int; 1999 Dec; 8(44):163-4. PubMed ID: 11503810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary prevention in the acute and early chronic phase after ischaemic stroke and transient ischaemic attacks with antiplatelet drugs--is antiplatelet monotherapy still reasonable?
    Diener HC; Weber R; Weimar C; Röther J
    Int J Clin Pract; 2011 May; 65(5):531-5. PubMed ID: 21489077
    [No Abstract]   [Full Text] [Related]  

  • 26. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
    Simmons BB; Yeo A; Fung K; ;
    Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
    Hankey GJ; Eikelboom JW
    Neurology; 2005 Apr; 64(7):1117-21. PubMed ID: 15824331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
    Wang Y; Chen W; Wang Y
    Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clopidogrel: secondary prevention of vascular ischaemic events.
    Misson J; Clark W; Kendall MJ
    J Clin Pharm Ther; 1998 Apr; 23(2):91-5. PubMed ID: 9786094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet agents for secondary prevention of ischemic stroke.
    Majid A; Delanty N; Kantor J
    Ann Pharmacother; 2001 Oct; 35(10):1241-7. PubMed ID: 11675854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clopidogrel plus aspirin for stroke prevention.
    Alberts MJ; Easton JD
    Stroke; 2002 Nov; 33(11):2546-7; author reply 2546-7. PubMed ID: 12411639
    [No Abstract]   [Full Text] [Related]  

  • 32. [New antiplatelet agents (platelet receptor blockers): has aspirin come out of place?].
    Tsakiris DA
    Praxis (Bern 1994); 2004 Jun; 93(23):1003-5. PubMed ID: 15233569
    [No Abstract]   [Full Text] [Related]  

  • 33. Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention.
    Weber R; Diener HC
    J Cell Mol Med; 2010 Oct; 14(10):2371-80. PubMed ID: 20738445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet therapy: a neurology perspective.
    Brass LM
    Manag Care; 2000 May; 9(5 Suppl):15-7. PubMed ID: 11729408
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiplatelet therapy: a neurology perspective.
    Brass LM
    Manag Care; 2000 Oct; 9(10 Suppl):13-5. PubMed ID: 11729420
    [No Abstract]   [Full Text] [Related]  

  • 37. Reversible shortness of breath caused by the antiplatelet agent, clopidogrel.
    Yi HJ; Cheong MA; Kim DW
    J Neurosurg Anesthesiol; 2013 Jan; 25(1):86-7. PubMed ID: 23027227
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
    Bretagne JF
    Presse Med; 2009 Dec; 38(12):1722-6. PubMed ID: 19914029
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin therapy should be first-line treatment in secondary prevention of stroke--against.
    Diener HC
    Stroke; 2002 Aug; 33(8):2138-9. PubMed ID: 12154277
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anticoagulation in atrial fibrillation. ACTIVE Study (Arterial fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events)].
    Meinertz T
    Internist (Berl); 2007 Aug; 48(8):874-5. PubMed ID: 17628764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.